GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valbiotis SA (XPAR:ALVAL) » Definitions » Price-to-Owner-Earnings

Valbiotis (XPAR:ALVAL) Price-to-Owner-Earnings : (As of Jun. 05, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Valbiotis Price-to-Owner-Earnings?

As of today (2024-06-05), Valbiotis's share price is €2.20. Valbiotis does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Valbiotis's Price-to-Owner-Earnings or its related term are showing as below:

During the past 9 years, the highest Price-to-Owner-Earnings of Valbiotis was 36.53. The lowest was 27.67. And the median was 31.99.


XPAR:ALVAL's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 34.035
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-05), Valbiotis's share price is €2.20. Valbiotis's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.59. Therefore, Valbiotis's PE Ratio for today is At Loss.

As of today (2024-06-05), Valbiotis's share price is €2.20. Valbiotis's EPS without NRI for the trailing twelve months (TTM) ended in was €-0.59. Therefore, Valbiotis's PE Ratio without NRI for today is At Loss.


Valbiotis Price-to-Owner-Earnings Historical Data

The historical data trend for Valbiotis's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valbiotis Price-to-Owner-Earnings Chart

Valbiotis Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only - 27.67 - - -

Valbiotis Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Valbiotis's Price-to-Owner-Earnings

For the Biotechnology subindustry, Valbiotis's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valbiotis's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Valbiotis's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Valbiotis's Price-to-Owner-Earnings falls into.



Valbiotis Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Valbiotis's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=2.20/-0.72
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Valbiotis  (XPAR:ALVAL) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Valbiotis Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Valbiotis's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Valbiotis (XPAR:ALVAL) Business Description

Traded in Other Exchanges
Address
12F rue Paul VATINE, Perigny, La Rochelle, FRA, 17180
Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of major metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.

Valbiotis (XPAR:ALVAL) Headlines

No Headlines